tryptophan methyl ester has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, H; Feng, H; Giglio, BC; He, L; Li, Z; Lu, H; Wang, H; Wang, M; Wu, Z | 1 |
| Andersen, MH; Sørensen, RB; thor Straten, P | 1 |
| Alsarraj, M; Antonia, SJ; Cantor, A; Dessureault, S; Extermann, M; Friberg, M; Jennings, R; Mellor, AL; Munn, DH | 1 |
| Germenis, AE; Karanikas, V; Zamanakou, M | 1 |
1 review(s) available for tryptophan methyl ester and Neoplasms
| Article | Year |
|---|---|
Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Topics: Animals; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Neoplasms; T-Lymphocytes; Tryptophan; Tumor Escape | 2007 |
3 other study(ies) available for tryptophan methyl ester and Neoplasms
| Article | Year |
|---|---|
Synthesis of 5-[
Topics: Animals; Fluorine Radioisotopes; HeLa Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Staining and Labeling; Tryptophan | 2017 |
Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".
Topics: Animals; CD8-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Enzyme Inhibitors; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Neoplasms; Rats; Tryptophan | 2009 |
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.
Topics: Animals; Cell Division; Flow Cytometry; Immune Tolerance; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms; T-Lymphocytes; Tryptophan; Tryptophan Oxygenase; Tumor Cells, Cultured | 2002 |